1. CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts
   Sheng-Mou Hou et al, 2017, Arthritis Research & Therapy CrossRef
2. A Heparan Sulfate Device for the Regeneration of Osteochondral Defects
   Jonathan H. Lee et al, 2019, Tissue Engineering Part A CrossRef
3. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis
   Li Li et al, 2020, BMC Musculoskeletal Disorders CrossRef
4. Comparative evaluation of the trabecular structure of the mandibular condyle, the levels of salivary cortisol, MMP-3, TNF-α, IL-1β in individuals with and without temporomandibular joint disorder
   Emine Ornek Akdogan et al, 2023, Journal of Stomatology, Oral and Maxillofacial Surgery CrossRef
5. MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint
   J. Xu et al, 2016, Osteoarthritis and Cartilage CrossRef
6. The Use of Synovial Fluid Analysis for Diagnosis of Temporomandibular Joint Disorders
   Gary F. Bouloux, 2018, Oral and Maxillofacial Surgery Clinics of North America CrossRef
7. MMP-3 in the peripheral serum as a biomarker of knee osteoarthritis, 40 years after open total knee meniscectomy
   Ioannis Pengas et al, 2018, Journal of Experimental Orthopaedics CrossRef
8. Hypothesis on the Pathogenesis of Osteoarthritis
   Stephan Neumann, 2015, MOJ Orthopedics & Rheumatology CrossRef
9. Separating friend from foe: Inhibition of TGF-β-induced detrimental SMAD1/5/9 phosphorylation while maintaining protective SMAD2/3 signaling in OA chondrocytes
   Nathalie G.M. Thielen et al, 2023, Osteoarthritis and Cartilage CrossRef
10. Chondrocyte Hypertrophy in Osteoarthritis: Mechanistic Studies and Models for the Identification of New Therapeutic Strategies
    Shikha Chawla et al, 2022, Cells CrossRef
11. Myrtol improves post‑traumatic knee osteoarthritis by regulation of reactive oxygen species, transforming growth factor β1 and apoptosis in a mouse model
    Liqun Duan et al, 2017, Experimental and Therapeutic Medicine CrossRef
12. Chondrotoxic effects of intra-articular injection of local anaesthetics in the rabbit temporomandibular joint
    C.Y. Asan et al, 2022, International Journal of Oral and Maxillofacial Surgery CrossRef
13. Upregulation of proangiogenic factors expression in the synovium of temporomandibular joint condylar hyperplasia
    Huilin Guo et al, 2016, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
14. Development of a simple osteoarthritis model useful to predict in vitro the anti-hypertrophic action of drugs
    Lyess Allas et al, 2020, Laboratory Investigation CrossRef
15. WITHDRAWN: New hypothesis on the pathogenesis of osteoarthritis
    Stephan Neumann, 2015, Medical Hypotheses CrossRef
16. Identification of Transcription Factors Responsible for a Transforming Growth Factor-β-Driven Hypertrophy-like Phenotype in Human Osteoarthritic Chondrocytes
    Nathalie G. M. Thielen et al, 2022, Cells CrossRef
17. Do matrix metalloproteinases play a role in degenerative disease of temporomandibular joint? A systematic review
    Lorena Marques Ferreira et al, 2016, CRANIO® CrossRef
18. The changing role of TGFβ in healthy, ageing and osteoarthritic joints
    Peter M. van der Kraan, 2017, Nature Reviews Rheumatology CrossRef
19. TGF-β dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression
    R. Wiegertjes et al, 2019, Osteoarthritis and Cartilage CrossRef
20. A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine
    Isabella Bartolotti et al, 2021, Journal of Clinical Medicine CrossRef
21. Transforming growth factor-β receptors: versatile mechanisms of ligand activation
    Zheng-Jie Chia et al, 2024, Acta Pharmacologica Sinica CrossRef
22. Retracted: Ligustrazine protects chondrocyte against IL‐1β induced injury by regulation of SOX9/NF‐κB signaling pathway
    Tao Yu et al, 2018, Journal of Cellular Biochemistry CrossRef